TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 2880687

Group type: EXPERIMENTAL
Intervention: 1000 mg acetaminophen (single dose) with 100 mg fenoldopam
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: 1000 mg acetaminophen (chronic dosing for 7 days) with 100 mg fenoldopam
Number of subjects: 19

Group type: COMPARATOR
Intervention: 100 mg fenoldopam alone
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: 100 mg fenoldopam with 1000 mg acetaminophen
Number of subjects: 19
Study: 29605408

Group type: EXPERIMENTAL
Intervention: COC‐ICSI
Number of subjects: 60

Group type: COMPARATOR
Intervention: C‐ICSI
Number of subjects: 60
Study: 26980323

Group type: EXPERIMENTAL
Intervention: Family-based mindfulness intervention (FBMI)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 120
Study: 25676256

Group type: EXPERIMENTAL
Intervention: Scarcity conditions
Number of subjects: 0
Study: 22147680

Group type: EXPERIMENTAL
Intervention: 6RM training protocol (3 sets of 6RM, twice per week for 8 weeks)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: 12RM training protocol (3 sets of 12RM, twice per week for 8 weeks)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned, but implied as the comparison between 6RM and 12RM)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Both groups (6RM and 12RM)
Number of subjects: 62
Study: 19637942

Group type: COMPARATOR
Intervention: Long-acting beta(2)-agonists
Number of subjects: 31020

Group type: COMPARATOR
Intervention: Tiotropium
Number of subjects: 31020

Group type: COMPARATOR
Intervention: Inhaled corticosteroids
Number of subjects: 31020

Group type: COMPARATOR
Intervention: Combination inhaled corticosteroid-long-acting beta(2)-agonist therapy
Number of subjects: 31020

Group type: EXPERIMENTAL
Intervention: Combination therapy vs Tiotropium
Number of subjects: 31020
Study: 17192290

Group type: COMPARATOR
Intervention: Endothelial-dependent vasodilation in obese women
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Endothelial-dependent vasodilation in lean women
Number of subjects: 60

Group type: COMPARATOR
Intervention: Endothelial-independent vasodilation
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Impact of time of sampling on endothelial-independent function
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Impact of obesity on endothelial-dependent microvascular function
Number of subjects: 60

Group type: COMPARATOR
Intervention: PAI-1/PAI-2 ratio in 1st trimester
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Contributors to 1st trimester PAI-1/PAI-2 ratio
Number of subjects: 60
Study: 14700518

Group type: EXPERIMENTAL
Intervention: valsartan 80 mg
Number of subjects: 120

Group type: COMPARATOR
Intervention: atenolol 50 mg
Number of subjects: 120
Study: 12469919

Group type: EXPERIMENTAL
Intervention: Alendronate 10 mg daily
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study: 9829840

Group type: COMPARATOR
Intervention: Cisplatin + 5-FU (Regimen A)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Cisplatin + 5-FU + recombinant interleukin 2 (Regimen B)
Number of subjects: 33
Study: 8273807

Group type: EXPERIMENTAL
Intervention: Indomethacin 50 mg P.O. t.i.d. for 3 consecutive days
Number of subjects: 20
Study: 2510260

Group type: EXPERIMENTAL
Intervention: Rioprostil 600 micrograms once-daily orally
Number of subjects: 207

Group type: COMPARATOR
Intervention: Ranitidine 150 mg once-daily orally
Number of subjects: 207
Study: 168493

Group type: EXPERIMENTAL
Intervention: Electrocardiographic response to exercise (Group A)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Electrocardiographic response to exercise (Group B)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Electrocardiographic response to exercise (Group C)
Number of subjects: 89
Study: 31905307

Group type: EXPERIMENTAL
Intervention: M‐ACT (multimodal acceptance and commitment therapy)
Number of subjects: 35
Study: 31740595

Group type: EXPERIMENTAL
Intervention: Stakeholder Engagement (SE) intervention
Number of subjects: 107

Group type: COMPARATOR
Intervention: Control group (not participating in SE)
Number of subjects: 107
Study: 30187159

Group type: EXPERIMENTAL
Intervention: Fluoxetine (n=15)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Prucalopride (n=14)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo (n=13)
Number of subjects: 48
Study: 27697605

Group type: EXPERIMENTAL
Intervention: i-gel supraglottic airway device
Number of subjects: 9070

Group type: COMPARATOR
Intervention: tracheal intubation
Number of subjects: 9070
Study: 24762369

Group type: EXPERIMENTAL
Intervention: Transactional Model-based Teaching program
Number of subjects: 200

Group type: COMPARATOR
Intervention: Ordinary Education Curriculum-based Teaching program
Number of subjects: 200
Study: 21823769

Group type: EXPERIMENTAL
Intervention: Computer-delivered intervention (CDI)
Number of subjects: 226

Group type: COMPARATOR
Intervention: Assessment-only control group
Number of subjects: 226

Group type: COMPARATOR
Intervention: Delayed-assessment control group
Number of subjects: 226
Study: 20562617

Group type: EXPERIMENTAL
Intervention: CVC self-care training (n = 42)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Standard CVC procedure provided by nurses (n = 40)
Number of subjects: 82
Study: 17702132

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Post-surgical adjuvant chemotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy or chemotherapy with subsequent surgery
Number of subjects: 0
Study: 15642569

Group type: EXPERIMENTAL
Intervention: Azimilide 75 mg
Number of subjects: 624

Group type: EXPERIMENTAL
Intervention: Azimilide 125 mg
Number of subjects: 624

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 624
Study: 11842294

Group type: EXPERIMENTAL
Intervention: Montelukast
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 9495402

Group type: EXPERIMENTAL
Intervention: Propofol 1%/sufentanil
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Desflurane/sufentanil
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Sevoflurane/sufentanil
Number of subjects: 80

Group type: COMPARATOR
Intervention: Isoflurane/sufentanil (standard anesthesia)
Number of subjects: 80
Study: 7644046

Group type: EXPERIMENTAL
Intervention: Warfarin
Number of subjects: 151

Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 151
Study: 2757939

Group type: EXPERIMENTAL
Intervention: UVA sunbeds (3 times weekly for 4 weeks)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Visible light sunbeds (3 times weekly for 4 weeks)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: UVA sunbeds and Visible light sunbeds
Number of subjects: 31
Study: 359779

Group type: EXPERIMENTAL
Intervention: Oral codeine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intramuscular codeine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oral oxycodone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intramuscular oxycodone
Number of subjects: 0
Study: 31854193

Group type: EXPERIMENTAL
Intervention: 20-minute mindful breathing
Number of subjects: 40

Group type: COMPARATOR
Intervention: 20-minute supportive listening
Number of subjects: 40
Study: 31034184

Group type: EXPERIMENTAL
Intervention: Liraglutide (up to 1.8 mg per day)
Number of subjects: 135

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Liraglutide
Number of subjects: 135
Study: 28192782

Group type: EXPERIMENTAL
Intervention: EMG biofeedback (14 sessions over 8 weeks)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control (usual care alone)
Number of subjects: 36
Study: 25376453

Group type: EXPERIMENTAL
Intervention: Progesterone
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Progesterone (≥4 cycles)
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Progesterone (≥4 years follow-up)
Number of subjects: 142

Group type: COMPARATOR
Intervention: Any fertility drug
Number of subjects: 142

Group type: COMPARATOR
Intervention: Gonadotrophins
Number of subjects: 142

Group type: COMPARATOR
Intervention: Clomiphene citrate
Number of subjects: 142

Group type: COMPARATOR
Intervention: Human chorionic gonadotrophins
Number of subjects: 142

Group type: COMPARATOR
Intervention: Gonadotrophin-releasing hormone analogues
Number of subjects: 142
Study: 23360509

Group type: EXPERIMENTAL
Intervention: Global radial strain (εR)
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: Global longitudinal strain (εL)
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: Global circumferential strain (εC)
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: Interaction of εL and εC
Number of subjects: 215
Study: 21760722

Group type: EXPERIMENTAL
Intervention: Breezhaler
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: HandiHaler
Number of subjects: 82
Study: 19801236

Group type: EXPERIMENTAL
Intervention: BioAggregate
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: MTA
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control (empty root canals)
Number of subjects: 56
Study: 17241835

Group type: EXPERIMENTAL
Intervention: Group A (109 women who removed their IUD for planning pregnancy)
Number of subjects: 205

Group type: COMPARATOR
Intervention: Group B (96 women who became pregnant or planned pregnancy after complicated IUD use)
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Group A
Number of subjects: 205

Group type: COMPARATOR
Intervention: Group B
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Group A and Group B
Number of subjects: 205
Study: 15133773

Group type: EXPERIMENTAL
Intervention: Brief counseling program directed at couples with cancer
Number of subjects: 0

Group type: COMPARATOR
Intervention: Waiting-list group (control)
Number of subjects: 0
Study: 11511297

Group type: EXPERIMENTAL
Intervention: Ultraviolet irradiation (2 minimal erythema doses)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Clobetasol (glucocorticoid)
Number of subjects: 0

Group type: COMPARATOR
Intervention: All-trans retinoic acid
Number of subjects: 0
Study: 10205771

Group type: EXPERIMENTAL
Intervention: Acetaminophen (APAP) 12.5 mg/kg
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: Ibuprofen (IBU) 5 mg/kg
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: Ibuprofen (IBU) 10 mg/kg
Number of subjects: 178

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 178
Study: 7972977

Group type: EXPERIMENTAL
Intervention: Tetracycline
Number of subjects: 40

Group type: COMPARATOR
Intervention: Mechlorethamine
Number of subjects: 40
Study: 2787232

Group type: EXPERIMENTAL
Intervention: Small-dose, frequent-injection group (injection volumes of less than 10 cc at mean intervals of three days)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Large-dose weekly treatment group (injection volumes greater than 15 cc at weekly intervals)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Small-dose, frequent-injection group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 0
Study: 5090826

Group type: EXPERIMENTAL
Intervention: Betamethasone 17-valerate (5 mg) retention enema
Number of subjects: 0

Group type: COMPARATOR
Intervention: Prednisolone 21-phosphate (20 mg) retention enema
Number of subjects: 0
Study: 31567351

Group type: EXPERIMENTAL
Intervention: Ramelteon 8 mg
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 29042415

Group type: EXPERIMENTAL
Intervention: Diet (goal: 10% weight loss, N = 118)
Number of subjects: 439

Group type: EXPERIMENTAL
Intervention: Exercise (225 min/wk moderate‐to‐vigorous activity, N = 117)
Number of subjects: 439

Group type: EXPERIMENTAL
Intervention: Diet + Exercise (N = 117)
Number of subjects: 439

Group type: COMPARATOR
Intervention: Control (N = 87)
Number of subjects: 439

Group type: EXPERIMENTAL
Intervention: Maintaining ≥10% of baseline weight loss
Number of subjects: 439

Group type: EXPERIMENTAL
Intervention: Maintaining any weight loss
Number of subjects: 439
Study: 26140473

Group type: EXPERIMENTAL
Intervention: Coenzyme Q10 (200mg/d for 12 weeks)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study: 23238444

Group type: EXPERIMENTAL
Intervention: Bilateral injection of 2.5-3.75 U BTA combined with sodium hyaluronate (SH) to the medial rectus muscle.
Number of subjects: 47

Group type: COMPARATOR
Intervention: Bilateral injection of 2.5-3.75 U BTA solution alone to the medial rectus muscle.
Number of subjects: 47
Study: 22088133

Group type: EXPERIMENTAL
Intervention: Healthy Eating Lifestyle Programme (12 fortnightly family sessions)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Enhanced standard care
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Healthy Eating Lifestyle Programme
Number of subjects: 200
Study: 19732191

Group type: EXPERIMENTAL
Intervention: Atraumatic restorative treatment (ART) restorations with cavity size between 2 and 3 mm or volumes 10.0-19.9 mm(3)
Number of subjects: 804
Study: 16997837

Group type: EXPERIMENTAL
Intervention: 0.6 mg kg(‐1) rocuronium
Number of subjects: 25

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 25
Study: 15160663

Group type: EXPERIMENTAL
Intervention: Colforsin (0.25 to 0.5 microg x kg(‐1) x min(‐1) loading dosage increased every 60 minutes)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 18
Study: 11301640

Group type: EXPERIMENTAL
Intervention: Rayon tape
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Acrylate adhesive tapes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All tapes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Individuals with varying responses
Number of subjects: 0
Study: 9051366

Group type: EXPERIMENTAL
Intervention: Acarbose (50 to 300 mg t.i.d.)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Acarbose
Number of subjects: 0
Study: 8298548

Group type: EXPERIMENTAL
Intervention: Asthma Symptom Checklist (ASC)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Living with Asthma Questionnaire (LWAQ)
Number of subjects: 42
Study: 3524065

Group type: EXPERIMENTAL
Intervention: Indomethacin (50 mg t.i.d.)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Acemethacin (60 mg t.i.d.)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Proglumethacin (150 mg t.i.d.)
Number of subjects: 32
Study: 29355982

Group type: EXPERIMENTAL
Intervention: iPad applications requiring specific motor skills, used for 30 minutes daily for 9 weeks
Number of subjects: 53

Group type: COMPARATOR
Intervention: Control class (no specific intervention mentioned)
Number of subjects: 53
Study: 26738646

Group type: EXPERIMENTAL
Intervention: 2-hour recovery time after liver biopsy
Number of subjects: 128

Group type: COMPARATOR
Intervention: 6-hour recovery time after liver biopsy
Number of subjects: 128
Study: 25358225

Group type: COMPARATOR
Intervention: ondansetron 4 mg
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: ondansetron 4 mg with dexamethasone 8 mg
Number of subjects: 40
Study: 22098167

Group type: EXPERIMENTAL
Intervention: Audiovisual distraction (AV) via a wall-mounted 32" television with wireless headphones
Number of subjects: 118

Group type: COMPARATOR
Intervention: No AV distraction (Control)
Number of subjects: 118
Study: 20008860

Group type: EXPERIMENTAL
Intervention: Desflurane at 1 MAC in oxygen 100%
Number of subjects: 44

Group type: COMPARATOR
Intervention: Oxygen 100% (control group)
Number of subjects: 44
Study: 18949663

Group type: EXPERIMENTAL
Intervention: Repeated testing
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Correct information
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Misleading information
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Delayed testing
Number of subjects: 0
Study: 16026700

Group type: EXPERIMENTAL
Intervention: VersaBond bone cement
Number of subjects: 59

Group type: COMPARATOR
Intervention: Palacos R bone cement
Number of subjects: 59
Study: 12538197

Group type: EXPERIMENTAL
Intervention: Indomethacin 1 mg (Group I, n=64)
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Indomethacin 2 mg (Group II, n=60)
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Methylprednisolone 80 mg (Group III, n=82)
Number of subjects: 206
Study: 10815751

Group type: EXPERIMENTAL
Intervention: Isradipine intravenous infusion
Number of subjects: 10

Group type: COMPARATOR
Intervention: Isradipine oral administration
Number of subjects: 10
Study: 8843933

Group type: EXPERIMENTAL
Intervention: Access to computer services (experimental group)
Number of subjects: 179

Group type: COMPARATOR
Intervention: Control group (no access to computer services)
Number of subjects: 179
Study: 1739343

Group type: EXPERIMENTAL
Intervention: BCG vaccination at third month of life
Number of subjects: 0

Group type: COMPARATOR
Intervention: BCG vaccination at birth
Number of subjects: 0
Study: 6496012

Group type: EXPERIMENTAL
Intervention: 0.05 mg/kg diazepam (4-5 min prior)
Number of subjects: 587

Group type: EXPERIMENTAL
Intervention: 0.05 mg/kg diazepam (8-10 min prior)
Number of subjects: 587

Group type: EXPERIMENTAL
Intervention: 0.1 mg/kg diazepam (4-5 min prior)
Number of subjects: 587

Group type: EXPERIMENTAL
Intervention: 0.1 mg/kg diazepam (8-10 min prior)
Number of subjects: 587

Group type: EXPERIMENTAL
Intervention: 0.05 mg/kg d-tubocurarine (4-5 min prior)
Number of subjects: 587

Group type: COMPARATOR
Intervention: Control group (no pretreatment)
Number of subjects: 587

Group type: EXPERIMENTAL
Intervention: Diazepam-pretreated groups (0.05 mg/kg and 0.1 mg/kg)
Number of subjects: 587

Group type: EXPERIMENTAL
Intervention: d-tubocurarine pretreatment
Number of subjects: 587
Study: 29476763

Group type: EXPERIMENTAL
Intervention: Cutting into half
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Grinding
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Crushing
Number of subjects: 25

Group type: COMPARATOR
Intervention: Whole film-coated bilayer tablets (reference)
Number of subjects: 25
Study: 26607935

Group type: EXPERIMENTAL
Intervention: Lipid-based nutrient supplements (LNS-PLs) 20 g/d, 118 kcal
Number of subjects: 4011
Study: 23464746

Group type: EXPERIMENTAL
Intervention: N2 O/O2 inhalation
Number of subjects: 56
Study: 23195001

Group type: EXPERIMENTAL
Intervention: sirolimus plus telmisartan
Number of subjects: 16

Group type: COMPARATOR
Intervention: telmisartan (control)
Number of subjects: 16
Study: 20018523

Group type: EXPERIMENTAL
Intervention: Pulsatile cardiopulmonary bypass (PCPB)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Linear cardiopulmonary bypass (LCPB)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Off-pump CABG (OPCABG)
Number of subjects: 60
Study: 18813045

Group type: EXPERIMENTAL
Intervention: Nitrous oxide-based anesthesia (n = 25)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Nitrous oxide-free anesthesia (control, n = 34)
Number of subjects: 59
Study: 15947284

Group type: EXPERIMENTAL
Intervention: Acetylcholine (ACh) infusion during hypoxia in HAPE-S subjects
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control subjects (HAPE-R) during hypoxia
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Pulmonary artery systolic pressure in HAPE-S subjects during hypoxia
Number of subjects: 18

Group type: COMPARATOR
Intervention: Pulmonary artery systolic pressure in control subjects during hypoxia
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Correlation of ACh infusion response with pulmonary artery systolic pressure in HAPE-S subjects
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Correlation of plasma nitrite with ACh-induced vasodilation in HAPE-S subjects
Number of subjects: 18
Study: 12895199

Group type: EXPERIMENTAL
Intervention: Combination oral contraceptive (40 microg ethinyloestradiol and 75 microg LNG)
Number of subjects: 10

Group type: COMPARATOR
Intervention: LNG alone (60 microg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Combination oral contraceptive and LNG alone
Number of subjects: 10
Study: 10480766

Group type: COMPARATOR
Intervention: Insulin Dosage Guide
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: Insulin Dosage Guide with rapid-acting insulin
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: Insulin Dosage Guide with insulin pump
Number of subjects: 143
Study: 7574000

Group type: EXPERIMENTAL
Intervention: Guanethidine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 1940126

Group type: EXPERIMENTAL
Intervention: vigabatrin
Number of subjects: 34

Group type: COMPARATOR
Intervention: carbamazepine
Number of subjects: 34
Study: 7024883

Group type: EXPERIMENTAL
Intervention: cis-platinum
Number of subjects: 100
Study: 31677711

Group type: EXPERIMENTAL
Intervention: Soy isoflavones (40 mg/day)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Cholecalciferol (50,000 IU/15 days)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Both soy isoflavones and cholecalciferol
Number of subjects: 4

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4
Study: 28195374

Group type: EXPERIMENTAL
Intervention: Weakly bent molecules with peripheral core substitution
Number of subjects: 0

Group type: COMPARATOR
Intervention: Weakly bent molecules with inside-directed fluorination
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Liquid-crystalline phases
Number of subjects: 0
Study: 25324332

Group type: EXPERIMENTAL
Intervention: Intervention group received eight cookies daily (11.5 g protein; 244 kcal) for 6 weeks.
Number of subjects: 175

Group type: COMPARATOR
Intervention: Control group received standard institutional diet without cookies.
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Intervention group received cookies.
Number of subjects: 175
Study: 20569099

Group type: EXPERIMENTAL
Intervention: 150 mg mifepristone administered 24 hours prior to sample collection
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control group (no mifepristone administered)
Number of subjects: 9
Study: 19667028

Group type: EXPERIMENTAL
Intervention: Acyclovir
Number of subjects: 703

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 703
Study: 17953377

Group type: EXPERIMENTAL
Intervention: Bupivacaine + Verapamil (group III)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Bupivacaine + Fentanil + Verapamil (group IV)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Epidural analgesia (general)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Intramuscular injection analgesia (group V)
Number of subjects: 50